Senate advances paired medical cannabis bills addressing Delta‑8, testing, caregivers and school access

Senator Vickers and Senator Escamilla led extended floor presentations and debate on two companion measures to refine Utah's medical cannabis program. Key sponsor points included reclassifying Delta‑8 products into the medical program, requiring identification of cannabinoids in product testing, clarifying that licenses are not commodities in a sale, restricting certain product forms (saying drinks should not be allowed under FDA food rules), and establishing staffing, training and background‑check protocols for medical cannabis pharmacy agents.

On workplace and first responders, sponsors said the bills would permit medical cannabis patients to be first responders but prohibit use within 12 hours of going on shift, aligning with safety concerns and federal restrictions on weapons possession after recent use. On schools, Senator Escamilla said the change "would only allow...when the principal agrees" that a parent or designated caregiver may administer a child's medically authorized dose on campus; she emphasized that "a child cannot carry that" and that the dose would remain in caregiver possession or be stored and administered per school procedures.

The chamber adopted a sponsor amendment clarifying that schools are not being asked to accept routine deliveries and that transport must be tied to dispensing for a named student. First Substitute SB190 was recorded as advancing on a roll call (clerk recorded 24 yeas, 3 nays, 2 absent). The transcript records First Substitute SB195 as advanced to third reading but includes inconsistent language in the recorded tally; the bill was amended on the floor to clarify school‑related provisions before being ordered to third reading.